About 50% of patients with rare diseases are children, which complicates patient selection and enrollment in clinical trials. Here, Dr. Cynthia Jackson offers recommendations on how to navigate these challenges by involving patients early in the planning stages and leveraging social networks to identify the right patients for a study.